Navarra, Pierluigi
 Distribuzione geografica
Continente #
NA - Nord America 8.963
EU - Europa 8.222
AS - Asia 5.613
SA - Sud America 1.169
AF - Africa 124
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 8
Totale 24.120
Nazione #
US - Stati Uniti d'America 8.746
SG - Singapore 2.597
DE - Germania 2.510
CN - Cina 1.359
IT - Italia 1.303
PL - Polonia 1.157
BR - Brasile 953
SE - Svezia 914
FR - Francia 562
VN - Vietnam 514
UA - Ucraina 481
GB - Regno Unito 366
IN - India 259
IE - Irlanda 253
FI - Finlandia 207
ID - Indonesia 167
RU - Federazione Russa 136
HK - Hong Kong 123
JP - Giappone 119
CA - Canada 92
TR - Turchia 92
NL - Olanda 79
AR - Argentina 78
MX - Messico 78
BD - Bangladesh 61
IQ - Iraq 61
ES - Italia 54
BE - Belgio 47
ZA - Sudafrica 42
EC - Ecuador 38
AT - Austria 29
CL - Cile 27
KR - Corea 25
SA - Arabia Saudita 25
VE - Venezuela 22
IR - Iran 21
UZ - Uzbekistan 21
AU - Australia 19
MA - Marocco 19
PK - Pakistan 19
CH - Svizzera 18
CZ - Repubblica Ceca 17
LT - Lituania 16
AZ - Azerbaigian 15
KE - Kenya 15
CO - Colombia 14
PH - Filippine 13
IL - Israele 12
KZ - Kazakistan 12
MY - Malesia 12
AE - Emirati Arabi Uniti 11
EG - Egitto 11
PE - Perù 11
BO - Bolivia 10
JO - Giordania 10
TT - Trinidad e Tobago 10
JM - Giamaica 9
GR - Grecia 8
HU - Ungheria 8
OM - Oman 8
PY - Paraguay 8
RO - Romania 8
BG - Bulgaria 7
LV - Lettonia 7
TH - Thailandia 7
TN - Tunisia 7
UY - Uruguay 7
CI - Costa d'Avorio 6
DO - Repubblica Dominicana 6
LB - Libano 6
PA - Panama 6
PT - Portogallo 6
ET - Etiopia 5
GE - Georgia 5
HN - Honduras 5
NP - Nepal 5
CR - Costa Rica 4
DK - Danimarca 4
NO - Norvegia 4
TW - Taiwan 4
BB - Barbados 3
BH - Bahrain 3
BY - Bielorussia 3
DZ - Algeria 3
KG - Kirghizistan 3
KW - Kuwait 3
MN - Mongolia 3
NG - Nigeria 3
PS - Palestinian Territory 3
RS - Serbia 3
SN - Senegal 3
SY - Repubblica araba siriana 3
XK - ???statistics.table.value.countryCode.XK??? 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BN - Brunei Darussalam 2
EU - Europa 2
GH - Ghana 2
HR - Croazia 2
Totale 24.085
Città #
Singapore 1.321
Chandler 1.208
Warsaw 1.057
Ashburn 1.038
San Jose 703
Jacksonville 319
San Mateo 274
Dublin 253
Beijing 248
Wilmington 230
Fairfield 229
Verona 227
New York 226
Milan 212
Nanjing 201
Houston 199
Ann Arbor 182
Los Angeles 181
Rome 178
Chicago 172
Ho Chi Minh City 172
Woodbridge 157
Jakarta 152
Lauterbourg 148
Nürnberg 144
Cattolica 142
Seattle 141
Bremen 127
Munich 125
Hefei 113
Hong Kong 111
Dearborn 110
Hanoi 107
The Dalles 103
Tokyo 101
Dallas 99
Boston 94
São Paulo 94
Cambridge 90
Kraków 88
Frankfurt am Main 87
Moscow 86
Lawrence 85
Helsinki 83
Council Bluffs 81
Nanchang 80
Buffalo 79
Marseille 77
Redwood City 66
Princeton 56
Santa Clara 53
Izmir 49
London 47
Brussels 45
Salt Lake City 44
Lancaster 43
Mountain View 43
Hangzhou 36
Kunming 36
Paris 36
Orem 35
Nuremberg 34
Phoenix 34
Boardman 33
North Bergen 33
Shenyang 33
Tianjin 32
University Park 32
Jiaxing 30
Pune 30
Leawood 29
Chennai 28
Fremont 28
Hyderabad 28
Rio de Janeiro 28
Düsseldorf 27
Toronto 27
Brooklyn 26
Guangzhou 26
Shanghai 26
Denver 25
Atlanta 24
Changsha 24
Da Nang 24
Stockholm 24
Belo Horizonte 23
Hebei 23
Kent 23
Philadelphia 23
Baghdad 22
Montreal 22
Redmond 21
Amsterdam 20
Brasília 20
Haiphong 20
Lappeenranta 20
Salvador 20
Falkenstein 19
Johannesburg 19
Mexico City 19
Totale 13.322
Nome #
Expression of iNOS, CD163 and ARG-1 taken as M1 and M2 markers of microglial polarization in human glioblastoma and the surrounding normal parenchyma 487
The human microglial HMC3 cell line: where do we stand? A systematic literature review 449
mTOR Inhibition Is Effective against Growth, Survival and Migration, but Not against Microglia Activation in Preclinical Glioma Models 437
The mTOR kinase inhibitors polarize glioma-activated microglia to express a M1 phenotype 436
Monocytes from depressed patients display an altered pattern of response to endotoxin challenge 416
mTOR kinase: a possible pharmacological target in the management of chronic pain 404
Novel sensitive, specific and rapid pharmacogenomic test for the prediction of abacavir hypersensitivity reaction: HLA-B*57:01 detection by real-time PCR 381
Cannabinoid agonist WIN55,212-2 induces apoptosis in cerebellar granule cells via activation of the CB1 receptor and downregulation of BCL-XL gene expression. 374
The mTOR kinase inhibitor rapamycin decreases iNOS mRNA stability in astrocytes 363
Proinflammatory-activated trigeminal satellite cells promote neuronal sensitization: relevance for migraine pathology 358
The effects of 5-HT3 receptor antagonists on cisplatin-induced emesis in the pigeon 317
Effects of remifentanil on human C20 microglial pro-inflammatory activation 271
Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression (Atazanavir and Lamivudine for treatment Simplification, AtLaS pilot study) 268
The role of small intestinal bacterial overgrowth in Parkinson's disease 248
Validation of a new HPLC-UV method for determination of the antibiotic linezolid in human plasma and in bronchoalveolar lavage 238
Full HTA di Emicizumab 229
Effects of the administration of epidermal growth factor receptor specific inhibitor cetuximab, alone and in combination with cisplatin, on proliferation and apoptosis of Hep-2 laryngeal cancer cells 228
Pharmacokinetics of etravirine in HIV-infected patients concomitantly treated with rifampin for tuberculosis 226
Antiretrovirals inhibit arginase in human microglia 216
Antiproliferative and Antimigratory Effects of mTOR Inhibitors in Paediatric Low-grade Gliomas Models. A Comparison between Rapamycin and Sapanisertib 213
Clinical experience with CTLA-4 blockade for cancer immunotherapy: From the monospecific monoclonal antibody ipilimumab to probodies and bispecific molecules targeting the tumor microenvironment 213
Trigeminal satellite cells express functional calcitonin gene-related peptide receptors, whose activation enhances interleukin-1β pro-inflammatory effects. 208
Cortistatin modulates the expression and release of corticotrophin releasing hormone in rat brain. Comparison with somatostatin and octreotide. 202
Death due to anaphylactic shock secondary to intravenous self-injection of Toradol: a case report and review of the literature 202
Buprenorphine inhibits bradykinin-induced release of calcitonin gene-related peptide from rat trigeminal neurons via both μ-opioid and nociceptin/orphanin peptide receptors. 197
Produzione in vitro e in vivo di interleuchina-1 dopo una convulsione febbrile 195
The mTOR kinase inhibitor rapamycin enhances the expression and release of pro-inflammatory cytokine interleukin 6 modulating the activation of human microglial cells 188
Phospho-mTOR expression in human glioblastoma microglia-macrophage cells 187
Relationship between antiretroviral plasma concentration and emergence of HIV-1 resistance mutations at treatment failure 186
Impact of regional copayment policy on selective serotonin reuptake inhibitor (SSRI) consumption and expenditure in Italy 185
AMPA- and P2X7-receptor-mediated facilitation of [3H]D-aspartate release from nerve terminals isolated from the rat caudal brainstem. 184
Valutazione costo-efficacia del percorso dei pazienti a rischio di epatite B sottoposti a test anti-HBV 182
Variability of raltegravir plasma levels in the clinical setting 181
Impact of regional copayment policy on selective serotonin reuptake inhibitor (SSRI) consumption and expenditure in Italy 180
Atazanavir and lopinavir with ritonavir alone or in combination: analysis of pharmacokinetic interaction and predictors of drug exposure. 176
N-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2 induced ERK-1 and -2 and HIF-1alpha induction pathway. 172
Trigeminal satellite cells express functional calcitonin gene-related peptide receptors, whose activation enhances interleukin-1β pro-inflammatory effects 171
Remifentanil-induced hyperalgesia in healthy volunteers: a systematic review and meta-analysis of randomized controlled trials 169
Valproic acid activity in androgen-sensitive and -insensitive human prostate cancer cells 169
Antiretrovirals inhibit arginase in human microglia 168
Darunavir/ritonavir and raltegravir coadministered in routine clinical practice: potential role for an unexpected drug interaction 167
Utilizzo degli antidepressivi e caratteristiche socio-economiche nelle regioni italiane. Evidenze da uno studio ecologico. 167
Stress-related biomarkers of dream recall and implicit memory under anaesthesia 167
Pro-inflammatory activation of a new immortalized human microglia cell line 167
Effects of olanzapine and quetiapine on corticotropin-releasing hormone release in the rat brain. 166
The impact of Regional co-payment and National reimbursement criteria on statins use in Italy: an interrupted time-series analysis 166
Validation of an UPLC-MS/MS Method for Quantitative Analysis of Raltegravir in Human Plasma Samples 162
Modulatory effects of the CCR5 antagonist maraviroc on microglial pro-inflammatory activation elicited by gp120 161
Tapentadol inhibits calcitonin gene-related peptide release from rat brainstem in vitro 161
Antinociceptive activity of buprenorphine and lumiracoxib in the rat orofacial formalin test: a combination analysis study. 160
Flupirtine inhibits calcitonin-gene related peptide release from rat brainstem in vitro. 159
Linezolid plasma and intrapulmonary concentrations in critically ill obese patients with ventilator-associated pneumonia: intermittent vs continuous administration 159
Pharmacokinetics of high-dose tigecycline in critically ill patients with severe infections 159
Relationship between self-reported adherence, antiretroviral drug concentration measurement and self-reported symptoms in patients treated for HIV-1 infection 155
beta-Carotene Downregulates the Steady-State and Heregulin-{alpha}-Induced COX-2 Pathways in Colon Cancer Cells. 152
The activation of type 1 corticotropin releasing factor receptor (CRF-R1) inhibits proliferation and promotes differentiation of neuroblastoma cells in vitro via p27Kip1 protein up-regulation and c-Myc mRNA down-regulation 152
Evaluation of efficacy, pharmacokinetics and tolerability of peptidomimetic aspartic proteinase inhibitors as cream formulation in experimental vaginal candidiasis 151
Pharmacokinetic variability of antiretroviral drugs and correlation with virological outcome: two years experience in routine clinical practice 150
A comparison between the assessments of progression-free survival by local investigators versus blinded independent central reviews in phase III oncology trials 150
A dual effect of some 5-HT3 receptor antagonists on cisplatin-induced emesis in the pigeon 147
Decreased plasma levels of darunavir/ritonavir in a vertically infected pregnant woman carrying multiclass-resistant HIV type-1 147
Proinflammatory-activated glioma cells induce a switch in microglial polarization and activation status, from a predominant M2b phenotype to a mixture of M1 and M2a/B polarized cells 146
Mid-dosing interval concentration of atazanavir and virological outcome in patients treated for HIV-1 infection. 145
Peripheral antinociceptive effects of low doses of naloxone in an in vivo and in vitro model of trigeminal nociception. 145
Use of High-Dose Nebulized Colistimethate in Patients with Colistin-Only Susceptible Acinetobacter baumannii VAP: Clinical, Pharmacokinetic and Microbiome Features 145
Death due to anaphylactic shock secondary to intravenous self-injection of Toradol: a case report and review of the literature. 144
Prolactin-lowering ability of (+/-)-idazoxan may be linked to a central noradrenergic-serotonergic interplay 143
Molecular and pharmacological evidence for a facilitatory functional role of presynaptic GLUK2/3 kainate receptors on GABA release in rat trigeminal caudal nucleus. 143
Lacosamide inhibits calcitonin gene-related peptide production and release at trigeminal level in the rat 143
Signaling pathways involved in lipopolysaccharide stimulation of prostaglandin production by rat hypothalamic astroglial cells 142
Trigeminal satellite cells modulate neuronal responses to triptans: relevance for migraine therapy. 142
Peripheral antinociceptive effects of low doses of naloxone in an in vivo and in vitro model of trigeminal nociception 142
Antiretroviral agents increase NO production in gp120/IFNγ-stimulated cultures of rat microglia via an arginase-dependent mechanism 142
Switch to maraviroc with darunavir/r, both QD, in patients with suppressed HIV-1 was well tolerated but virologically inferior to standard antiretroviral therapy: 48-Week results of a randomized trial 142
Flupirtine antinociception in the rat orofacial formalin test: an analysis of combination therapies with morphine and tramadol. 141
The effects of CHF6467, a new mutated form of NGF, on cell models of human glioblastoma. A comparison with wild-type NGF 141
Cortistatin modulates calcitonin gene-related peptide release from neuronal tissues of rat. Comparison with somatostatin. 139
Rapamycin reduces clinical signs and neuropathic pain in a chronic model of experimental autoimmune encephalomyelitis 139
Detection of HLA-B*57:01 by real-time PCR: implementation into routine clinical practice and additional validation data 138
Local Investigators Significantly Overestimate Overall Response Rates Compared to Blinded Independent Central Reviews in Phase 2 Oncology Trials 138
Comparative Analysis of Real-Time Polymerase Chain Reaction Methods to Typing HLA-B*57:01 in HIV-1-Positive Patients 136
P2X7 receptors exert a permissive effect on the activation of presynaptic AMPA receptors in rat trigeminal caudal nucleus glutamatergic nerve terminals 136
The in vitro rabbit whole bladder as a model to investigate the urothelial transport of anticancer agents The ONCOFID-P paradigm. 135
Optimizing Patient Selection to Maximize Drug Efficacy: the Expanding Role of Pharmacogenomics in the Clinical Development of Pembrolizumab for the Treatment of Non-small Cell Lung Cancer 135
Pdia3 expression in glioblastoma modulates macrophage/microglia pro-tumor activation 135
Involvement of mTOR kinase in cytokine-dependent microglial activation and cell proliferation 134
Vascular endothelial growth factor receptor 1 in glioblastoma-associated microglia/macrophages 131
Diverging effects of cortistatin and somatostatin on the production and release of prostanoids from rat cortical microglia and astrocytes 130
Linezolid plasma and intrapulmonary concentrations in critically ill obese patients with ventilator-associated pneumonia: intermittent vs continuous administration 128
Blockade of CCR5 receptor prevents M2 microglia phenotype in a microglia-glioma paradigm 128
A proof-of-concept study on CGRP plasma levels of migraineurs during a 6-month treatment with ERENUMAB 128
Exploiting microglial functions for the treatment of glioblastoma 127
Kinetics of Intestinal Presence of Spores Following Oral Administration of Bacillus clausii Formulations: Three Single-Centre, Crossover, Randomised, Open-Label Studies 127
Correlation between algogenic effects of calcitonin-gene-related peptide (CGRP) and activation of trigeminal vascular system, in an in vivo experimental model of nitroglycerin-induced sensitization 126
Aspirin inhibits cancer stem cells properties and growth of glioblastoma multiforme through Rb1 pathway modulation 126
REMIFENTANIL DOES NOT AFFECT HUMAN MICROGLIAL IMMUNE ACTIVATION IN RESPONSE TO PRO-INFLAMMATORY CYTOKINES 125
Tenofovir discontinuation could predispose to urolithiasis in atazanavir-treated patients 125
Trigeminal satellite cells modulate neuronal responses to triptans: relevance for migraine therapy. 125
Carbon monoxide as a novel neuroendocrine modulator: Inhibition of stimulated corticotropin-releasing hormone release from acute rat hypothalamic explants 125
Pro-inflammatory-activated glioma cells induce a switch in microglial polarization and activation status, from a predominant M2b phenotype to a mixture of M1 and M2a/b polarized cells 124
Totale 18.885
Categoria #
all - tutte 85.636
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.636


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021346 0 0 0 0 0 0 0 0 0 99 206 41
2021/20221.722 151 112 26 102 121 65 42 237 72 96 431 267
2022/20233.125 360 455 242 523 244 370 115 271 349 48 93 55
2023/20241.641 90 400 66 153 84 219 119 55 30 58 182 185
2024/20253.394 77 88 226 121 260 137 60 179 548 302 923 473
2025/20267.241 1.058 248 504 911 1.300 382 1.455 349 553 481 0 0
Totale 24.389